These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 6736960

  • 1. MDL 72145, an enzyme-activated irreversible inhibitor with selectivity for monoamine oxidase type B.
    Zreika M, McDonald IA, Bey P, Palfreyman MG.
    J Neurochem; 1984 Aug; 43(2):448-54. PubMed ID: 6736960
    [Abstract] [Full Text] [Related]

  • 2. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
    Palfreyman MG, McDonald IA, Bey P, Schechter PJ, Sjoerdsma A.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 Aug; 12(6):967-87. PubMed ID: 3266532
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In-vivo effects of (E)-2-(3',4'-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat. Selective inhibition of semicarbazide-sensitive amine oxidase in vascular and brown adipose tissues.
    Elliott J, Callingham BA, Barrand MA.
    J Pharm Pharmacol; 1989 Jan; 41(1):37-41. PubMed ID: 2565962
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B.
    Kindt MV, Heikkila RE.
    Life Sci; 1986 Apr 21; 38(16):1459-62. PubMed ID: 3084895
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. (E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine: a selective, enzyme-activated inhibitor of type B monoamine oxidase.
    Bey P, Fozard J, Lacoste JM, McDonald IA, Zreika M, Palfreyman MG.
    J Med Chem; 1984 Jan 21; 27(1):9-10. PubMed ID: 6690689
    [No Abstract] [Full Text] [Related]

  • 10. MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.
    Zreika M, Fozard JR, Dudley MW, Bey P, McDonald IA, Palfreyman MG.
    J Neural Transm Park Dis Dement Sect; 1989 Jan 21; 1(4):243-54. PubMed ID: 2597310
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M, Jain S, Baquer NZ.
    Biochem Pharmacol; 1990 Nov 15; 40(10):2215-8. PubMed ID: 2123104
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of rat aorta semicarbazide-sensitive amine oxidase by 2-phenyl-3-haloallylamines and related compounds.
    Lyles GA, Marshall CM, McDonald IA, Bey P, Palfreyman MG.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2847-53. PubMed ID: 3632710
    [Abstract] [Full Text] [Related]

  • 16. Studies on the behaviour of semicarbazide-sensitive amine oxidase in Sprague-Dawley rats treated with the monoamine oxidase inhibitor tranylcypromine.
    Fitzgerald DH, Tipton KF, Lyles GA.
    J Neural Transm Suppl; 1998 Sep 01; 52():259-64. PubMed ID: 9564625
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A, Olmos G, Boronat MA, Lizcano JM, Unzeta M, García-Sevilla JA.
    Br J Pharmacol; 1997 Jul 01; 121(5):901-12. PubMed ID: 9222546
    [Abstract] [Full Text] [Related]

  • 18. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ, Benedetti MS.
    J Neurochem; 1983 Jun 01; 40(6):1534-41. PubMed ID: 6406646
    [Abstract] [Full Text] [Related]

  • 19. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.
    Fuller RW, Hemrick-Luecke SK, Molloy BB.
    Biochem Pharmacol; 1983 Apr 01; 32(7):1243-9. PubMed ID: 6847714
    [Abstract] [Full Text] [Related]

  • 20. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
    Youdim MB, Gross A, Finberg JP.
    Br J Pharmacol; 2001 Jan 01; 132(2):500-6. PubMed ID: 11159700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.